CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism

J Antibiot (Tokyo). 1978 Dec;31(12):1211-7. doi: 10.7164/antibiotics.31.1211.

Abstract

A new antitumor antibiotic is produced in fermentation liquors of Streptomyces zelensis sp.n. The antibiotic is biologically active at extremely low concentrations. At 40 pg/ml, it inhibited 90% of the growth of L1210 cells in culture in tube dilution assays. The minimal inhibitory concentrations against Gram-positive bacteria is between 1 approximately 10 ng/ml, while these values for Gram-negative bacteria and fungi are mostly under 1 microgram/ml. A microbiological assay with Bacillus subtilis can detect concentrations of 1 approximately 2 ng/ml.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / biosynthesis
  • Antibiotics, Antineoplastic / pharmacology*
  • Bacillus subtilis / drug effects
  • Cells, Cultured
  • Leukemia L1210 / drug therapy
  • Mice
  • Sarcina / drug effects
  • Streptomyces / classification
  • Streptomyces / metabolism*

Substances

  • Antibiotics, Antineoplastic